397 related articles for article (PubMed ID: 20306293)
1. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Loehberg CR; Jud SM; Haeberle L; Heusinger K; Dilbat G; Hein A; Rauh C; Dall P; Rix N; Heinrich S; Buchholz S; Lex B; Reichler B; Adamietz B; Schulz-Wendtland R; Beckmann MW; Fasching PA
Breast Cancer Res Treat; 2010 May; 121(1):101-10. PubMed ID: 20306293
[TBL] [Abstract][Full Text] [Related]
2. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
[TBL] [Abstract][Full Text] [Related]
3. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium.
Rimer BK; Schildkraut JM; Lerman C; Lin TH; Audrain J
Cancer; 1996 Jun; 77(11):2348-55. PubMed ID: 8635106
[TBL] [Abstract][Full Text] [Related]
4. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
Kinney AY; Richards C; Vernon SW; Vogel VG
Prev Med; 1998; 27(5 Pt 1):713-9. PubMed ID: 9808803
[TBL] [Abstract][Full Text] [Related]
5. Screening and prevention of breast cancer in primary care.
Tice JA; Kerlikowske K
Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
[TBL] [Abstract][Full Text] [Related]
6. The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs.
Fasching PA; von Minckwitz G; Fischer T; Kaufmann M; Schultz-Zehden B; Beck H; Lux MP; Jacobs V; Meden H; Kiechle M; Beckmann MW; Paepke S
Breast Cancer Res Treat; 2007 Jan; 101(1):95-104. PubMed ID: 17033928
[TBL] [Abstract][Full Text] [Related]
7. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
[TBL] [Abstract][Full Text] [Related]
8. Recruiting high risk women into a breast cancer health promotion trial.
Lerman C; Rimer BK; Daly M; Lustbader E; Sands C; Balshem A; Masny A; Engstrom P
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):271-6. PubMed ID: 8019378
[TBL] [Abstract][Full Text] [Related]
9. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
10. Addressing the support needs of women at high risk for breast cancer: evidence-based care by advanced practice nurses.
Stacey D; DeGrasse C; Johnston L
Oncol Nurs Forum; 2002 Jul; 29(6):E77-84. PubMed ID: 12096298
[TBL] [Abstract][Full Text] [Related]
11. Men's and women's knowledge and perceptions of breast cancer and mammography screening.
Chamot E; Perneger TV
Prev Med; 2002 Mar; 34(3):380-5. PubMed ID: 11902856
[TBL] [Abstract][Full Text] [Related]
12. Associations in breast and colon cancer screening behavior in women.
Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
[TBL] [Abstract][Full Text] [Related]
13. Intervention to increase screening mammography among women 65 and older.
Michielutte R; Sharp PC; Foley KL; Cunningham LE; Spangler JG; Paskett ED; Case LD
Health Educ Res; 2005 Apr; 20(2):149-62. PubMed ID: 15254001
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention Indication Score: a user-friendly tool for prevention of breast cancer - pilot analysis.
Layeequr Rahman R; Crawford S
Breast; 2009 Oct; 18(5):289-93. PubMed ID: 19716702
[TBL] [Abstract][Full Text] [Related]
15. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
16. Predicting compliance in a breast cancer prevention trial.
Maurice A; Howell A; Evans DG; O'Neil AC; Scobie S
Breast J; 2006; 12(5):446-50. PubMed ID: 16958964
[TBL] [Abstract][Full Text] [Related]
17. The 2003 Australian Breast Health Survey: survey design and preliminary results.
Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
[TBL] [Abstract][Full Text] [Related]
18. [Chemoprevention of breast cancer: a literature review and report on the current status in Germany].
Paepke S; V Minckwitz G; Kaufmann M; Schwarz-Boeger U; Jacobs VR; Aigner M; Pfeifer K; Ehmer M; Hüttner C; Blohmer JU; Kiechle M
Zentralbl Gynakol; 2003 Sep; 125(9):338-45. PubMed ID: 14569515
[TBL] [Abstract][Full Text] [Related]
19. Knowledge, attitudes, and practices surrounding breast cancer screening in educated Appalachian women.
Leslie NS; Deiriggi P; Gross S; DuRant E; Smith C; Veshnesky JG
Oncol Nurs Forum; 2003; 30(4):659-67. PubMed ID: 12861325
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer prevention in community clinics: will low-income Latina patients participate in clinical trials?
Mandelblatt J; Kaufman E; Sheppard VB; Pomeroy J; Kavanaugh J; Canar J; Pallandre L; Cullen J; Huerta E
Prev Med; 2005 Jun; 40(6):611-8. PubMed ID: 15850856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
